Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RP (Retinitis Pigmentosa)”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07290530
What this trial is testing

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Who this might be right for
Retinitis Pigmentosa (RP)Usher Syndrome
Nacuity Pharmaceuticals, Inc. 80
Testing effectiveness (Phase 2)Study completedNCT02320812
What this trial is testing

Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa (RP)
jCyte, Inc 28
Testing effectiveness (Phase 2)Study completedNCT03073733
What this trial is testing

Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
jCyte, Inc 84
Testing effectiveness (Phase 2)Ended earlyNCT05085964
What this trial is testing

An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2
Laboratoires Thea 21
Testing effectiveness (Phase 2)Looking for participantsNCT06789445
What this trial is testing

Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Who this might be right for
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
BlueRock Therapeutics 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07282457
What this trial is testing

Prospective, Randomized, Sham-controlled, Dose-finding I/II Trial of Safety and Efficacy of Modified Optogenetic Gene Therapy (ZM-02 Injection)

Who this might be right for
Retinitis Pigmentosa (RP)
Zhongmou Therapeutics 21
Not applicableStudy completedNCT00231010
What this trial is testing

Molecular Genetics of Retinal Degenerations

Who this might be right for
Retinal DegenerationRetinitis Pigmentosa
National Eye Institute (NEI) 3,549
Testing effectiveness (Phase 2)Ended earlyNCT05392751
What this trial is testing

Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa

Who this might be right for
Retinitis PigmentosaRetinitis Pigmentosa Syndrome
Endogena Therapeutics, Inc 14
Not applicableStudy completedNCT03597399
What this trial is testing

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

Who this might be right for
Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
Spark Therapeutics, Inc. 87
Not applicableStudy completedNCT02575430
What this trial is testing

Natural History Study in Inherited Retinal Disease Subjects Caused by Mutations in RPE65 or LRAT

Who this might be right for
Leber Congenital Amaurosis (LCA)Retinitis Pigmentosa (RP)
QLT Inc. 59
Testing effectiveness (Phase 2)Study completedNCT03780257
What this trial is testing

Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
ProQR Therapeutics 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT03963154
What this trial is testing

Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

Who this might be right for
Retinitis Pigmentosa
Centre d'Etude des Cellules Souches 7
Testing effectiveness (Phase 2)Looking for participantsNCT07807111
What this trial is testing

Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy

Who this might be right for
Retinitis Pigmentosa (RP)Rod Cone Dystrophy
SparingVision 27
Not applicableStudy completedNCT03845218
What this trial is testing

Retinitis Pigmentosa Clinical Measures and Repeatability Testing of Potential Outcome Measures

Who this might be right for
Retinitis Pigmentosa
National Eye Institute (NEI) 49
Testing effectiveness (Phase 2)Looking for participantsNCT06891885
What this trial is testing

Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa

Who this might be right for
Retinitis Pigmentosa
Sumitomo Pharma America, Inc. 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT06912633
What this trial is testing

Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)

Who this might be right for
Retinitis Pigmentosa
jCyte, Inc 31
Not applicableStudy completedNCT04926129
What this trial is testing

Natural History of the Progression of X-Linked Retinitis Pigmentosa

Who this might be right for
X-Linked Retinitis Pigmentosa
NightstaRx Ltd, a Biogen Company 201
Large-scale testing (Phase 3)Ended earlyNCT05158296
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 7
Not applicableStudy completedNCT03381235
What this trial is testing

Exercise and RP (AVAMC and Emory)

Who this might be right for
Retinitis Pigmentosa
Emory University 4
Testing effectiveness (Phase 2)Study completedNCT02556736
What this trial is testing

AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

Who this might be right for
Advanced Retinitis Pigmentosa
AbbVie 14
Next Page